Chih-Hsin Hsu
Overview
Explore the profile of Chih-Hsin Hsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang W, Cheng Y, Hsu C, Wu Y, Cheng C, Ho W, et al.
Acta Cardiol Sin
. 2024 Nov;
40(6):716-728.
PMID: 39582841
In the past, patients with pulmonary hypertension (PH) were advised to avoid exercise due to concerns that it might strain cardiac function and exacerbate symptoms. However, recent evidence indicates that...
2.
Chiu W, Chan L, Masud J, Hong C, Chien Y, Hsu C, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(2):55.
PMID: 39077396
Background: Prolonged length of stay (LOS) following targeted temperature management (TTM) administered after cardiac arrest may affect healthcare plans and expenditures. This study identified risk factors for prolonged LOS in...
3.
Chao H, Yee B, Hsu C, Chen H, Lau E
Sleep Med Rev
. 2024 Jul;
77:101972.
PMID: 39032322
Precapillary pulmonary hypertension (PcPH) is associated with the development of sleep-related disorders and impairment of sleep quality. With growing recognition of the clinical relevance of sleep-related conditions in PcPH, this...
4.
5.
Cheng M, Kuo H, Chang C, Chang J, Liu I, Hsieh C, et al.
Biomed Pharmacother
. 2024 Apr;
174:116572.
PMID: 38626519
Epigenetic regulation and mitochondrial dysfunction are essential to the progression of idiopathic pulmonary fibrosis (IPF). Curcumin (CCM) in inhibits the progression of pulmonary fibrosis by regulating the expression of specific...
6.
Li Y, Wang C, Hung C, Wu Y, Hsu C, Tsou Y, et al.
Acta Cardiol Sin
. 2024 Mar;
40(2):148-171.
PMID: 38532817
Heart failure with preserved ejection fraction (HFpEF) is a multi-organ systemic syndrome that involves cardiac and extra-cardiac pathophysiological abnormalities. Its growing prevalence causes a major public concern worldwide. HFpEF is...
7.
Chen C, Mei-Tzu W, Sung S, Wu Y, Hsu C, Ho W, et al.
Heliyon
. 2024 Mar;
10(6):e27537.
PMID: 38515682
Background: Demographics of pulmonary hypertension (PH) has changed a lot over the past forty years. Several recent registries noted an increase in mean age of PH but only a few...
8.
Yang K, Wang M, Tao C, Wu Y, Hsu C, Liao W, et al.
J Chin Med Assoc
. 2024 Jan;
87(3):273-279.
PMID: 38252515
Background: The long-term outcome on patients with chronic thromboembolic pulmonary hypertension (CTEPH) has not been ideal after standard medical treatment. However, good outcome for patients with CTEPH after interventions such...
9.
Kuo L, Wang Y, Chen P, Lin W, Wang W, Shih C, et al.
JTCVS Open
. 2024 Jan;
16:582-601.
PMID: 38204699
Objective: We aimed to investigate the characteristics of nosocomial infections (NIs) and the impact of prophylactic antibiotic administration on NI outcomes in patients who underwent extracorporeal cardiopulmonary resuscitation (ECPR). Methods:...
10.
Chang W, Lee W, Lin Y, Shih J, Hong C, Chen Z, et al.
J Am Heart Assoc
. 2023 Nov;
12(23):e031435.
PMID: 38014665
Background: Pulmonary artery hypertension (PAH) is a fatal disease characterized by a complex pathogenesis. Exosomes containing microRNAs (miRs) have emerged as a novel biomarker. Transpulmonary exosomal miRs offer valuable insights...